Inicio > Anestesiología y Reanimación > Hipnoterapia en el tratamiento del dolor de la Neuritis Cubital Hanseniana. Presentación de un caso > Página 6

Hipnoterapia en el tratamiento del dolor de la Neuritis Cubital Hanseniana. Presentación de un caso

166:5883-8.

6. Gómez JR, Moll F. Lepra: enfermedad olvidada. Situación actual y trabajo sobre el terreno <http://www.nexusediciones.com/pdf/ee2005_2/s-7-2-004.pdf> [consulta: 12 de enero del 2008].

7. World Health Organization. A guide to leprosy control. 2 ed. Geneva:WHO, 1988: 278.

8. Rao PS. Current epidemiology of leprosy in India. Rev Lepr 2006; 77:292-4.

9. Ooi WW, Srinivasan J. Leprosy and the peripheral nervous system: basic and clinical aspects. Muscle Nerve 2004; 30: 393-409.

10. Kajihara H, Paturusi IA, Saleh RM, Rasyad C, Ikuta Y. Light and electron microscopic study of peripheral nerve damage in patients with lepromatous leprosy (LL) and borderline lepromatous leprosy (BL).Hiroshima J Med Sci 2000; 49:83-92.

11. Abbot NC, Beck JS, Mostofi S, Weiss F.Sympathetic vasomotor dysfunction in leprosy patients: comparison with electrophysiological measurement and qualitative sensation testing. Neurosci Lett 1996; 206:57-60.

12. Van Brakel WH, Khawas IB. Nerve function impairment in leprosy: an epidemiological and clinical study. Part 2:Results of steroid treatment. Lepr Rev
1996; 67:104-18.

13. Garbino JA. Manejo clínico das diferentes formas de comprometimento da neuropatia hanseniana. Hansen Int Especial 1998:93-9.

14. Saunderson P, Gebre S, Desta K, Byass P,Lockwood DN. The pattern of leprosyrelated neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev 2000;71:285-308.

15. Croft RP, Nicholls PG, Richardus JH,Smith WC. Incidence rates of acute nerve function impairment in leprosy: a prospective cohort analysis after 24 months (The Bangladesh Acute Nerve Damage Study). Lepr Rev 2000; 71:18-33.

16. Solomon S, Kurian N, Ramadas P, Rao PS. Incidence of nerve damage in leprosypatients treated with MDT. Int J Lepr Other Mycobact Dis 1998; 66:451-6.

17. Baron R. Neuropathic pain: the long path from mechanisms to mechanism-based treatment. Anaesthesist 2000; 49:373-86.

18. Grimaud J, Chapuis F, Verchot B, Millan J. How to detect neuropathy in leprosy. Ver Neurol (Paris) 1994; 150:785-90.

19. Nunzi E, Leiker Dl. Valutazione clinica del paziente. Indagini di laboratório. In:Manuale di leprologia. Bologna:Associazione italiana amici di Raoul Follerau; 1990. p.57-68.

20. Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Manual de prevenção de incapacidades.Brasília: Ministério da Saúde; 2001.p. 107.

21. Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Guia para o controle da hanseníase.(Cadernos de Atenção Básica n. 10, Série A: Normas e Manuais Técnicos, n.111).Brasília: Ministério da Saúde; 2002. p. 89.

22. Bell-Krotoski J. Advances in sensibility evaluation. Hand Clin 1991; 7:527-46.

23. Bell-Krotoski JA, Buford WL Jr. The force/time relationship of clinically used
sensory testing instruments. J Hand Ther 1997; 10:297-309.

24. American Society of Hand Therapists.Clinical assesment recommendations.
Michigan: American Society of Hand Therapists; 2002. p.76-7.

25. Brandsma JW. Terminology in leprosy rehabilitation and guidelines for nerve function assessment. Trop Geogr Med 1994; 46:88-92.

26. Saúde para a vida treinamento para prevenção de incapacidades em hanseníase.Brasília: Ministério da Saúde e American Leprosy Mission; 1998 J.5 p.1

27. Dastur DK, Porwal GL, Shah JS, Revankar CR. Immunological implications of necrotic, cellular and vascular changes in leprous neuritis: light and electron
microscopy. Lep Rev 1982; 53:45-65.

28. Becx-Bleumink M, Berhe D. Occurrence of reactions, their diagnosis and
management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int J Lepr Other Mycobact Dis 1992; 60:173-84.

29.1Álvarez-Nemegyei, J., Negreros-Castillo, A., Nuño-Gutiérrez, B. L., Álvarez-Berzunza, J. y Alcocer-Martínez,L. M. (2007). Eficacia de la hipnosis ericksoniana en el síndrome de fibromialgia en mujeres. RevistaMédica Instituto Mexicana del Seguro Social, 45(4), 395-401. Recuperado de http://www.medigraphic.com/pdfs/imss/im-2007/im074l.pdf

30. Montgomery GH, DuHamel KN, Redd WH. A m e t a -analysis of hypnotically induced analgesia: How efecctive is hypnosis. Int J Clin Exp Hypn 2000; 48:1 3 8 – 5 3 .

31 . Montomery GH, Weltz CR, Seltz M, Bovbjer DH.Brief presurgery hypnosis reduces distress and pain in excisional breast biopsy patients. Int J Clin Exp Hypn 2002; 50: 17-32.

32 . Ashton C, Whitworth GC, Seldomridge JA, et al.Self-hypnosis reduces anxiety following coronary artery bypass surg e r y. A prospective, randomized trial.J Cardiovasc Surg 1997; 38: 69-75.

33 . Blankfield RP. Suggestion, relaxation, and hypnosis as adjuncts in the care of surgery patients: a review of the literature. Am J Clin Hypn 1991; 33:172-86.

34 . Enquist B, Björklund C, Engman M. et al. Preoperative hypnosis reduces postoperative vomiting after s u rgery of the breasts. Acta Anaesthesiol Scand 1997;41: 1028-32.

35 . Mauer MH, Burnett, KF, Ouellette EA, et al. Medical hypnosis and orthopedic hand surgery: pain perception,postoperative recovery and therapuetic comfort.Int J Clin Exp Hypn 1999; 47: 144-61.

36 . Chaves JF. Hypnotic control of clinical pain. En:Spanos NP, Chaves JF (Eds.). Hypnosis: the cognitive-behavioral perspective. Buffalo NY: Rometheus,1989. p. 242-72.

37-Organización Mundial de la Salud.: «Tratamiento del Dolor y Tratamiento Paliativo en el Cáncer»,7º Congreso Virtual de Psiquiatría. Interpsiquis Febrero 2006. Psiquiatria.com -18-.Ginebra, 1990: ( 40 – 53 ). 38 -Sociedad Cubana de Oncología.:»Cáncer». Editorial Hermanos Loynaz. Pinar del Río. 1995:(16 -22). 39 -Álvarez Fontanet Jorge Joaquín.: «Tratamiento del Dolor». Edición Científico – Técnica. Ciudad de La Habana, 1998: (40 – 43).